Navigation Links
InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
Date:12/10/2008

or information. InterMune's actual results could differ materially from those described in InterMune's forward-looking statements.

Factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in InterMune's most recent annual report on Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to the long, expensive and uncertain clinical development and regulatory process, including having no unexpected safety, toxicology, clinical or other issues or delays in anticipated timing of the regulatory approval process; (ii) risks related to failure to achieve the clinical trial results required to commercialize our product candidates; and (iii) risks related to timely patient enrollment and retention in clinical trials. The risks and other factors discussed above should be considered only in connection with the fully discussed risks and other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web site at http://www.intermune.com.

Pegasys(R) and Copegus(R) are registered trademarks of Roche.


'/>"/>
SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. Spherix Reports Second Quarter Earnings
11. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , Chief Financial Officer of Neurocrine Biosciences, will be ... New York City . The ... 11:25am ET (8:25am PT).  The presentation will be webcast ... http://www.neurocrine.com .   Listeners are encouraged ...
(Date:9/2/2015)... 2, 2015  ArmaGen, Inc., a privately held ... treat severe neurological disorders, announced today that the ... Phase 1/2a clinical trial of AGT-181 in patients ... AGT-181 is an investigational enzyme replacement ... The most severe form of MPS I, Hurler ...
(Date:9/2/2015)... -- Aethlon Medical, Inc. (Nasdaq: AEMD ), today announced that ... at the Rodman & Renshaw 17th Annual Global Investment Conference ... a.m. ET on Thursday, September 10, 2015. The ... audio webcast which can be accessed by visiting the investor ... . The webcast will be archived for thirty days.  ...
Breaking Medicine Technology:ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4
... June 8, 2011 Cellular Dynamics International, Inc. ... Inc ., who will distribute CDI,s iCell® Cardiomyocytes , ... cells (iPSCs), in Japan. This distribution agreement ... Dr. James Thomson and Dr. Shinya Yamanaka ...
... June 8, 2011 Reportlinker.com announces ... is available in its catalogue: ... Global Pipeline Analysis,Competitive Landscape and Market ... http://www.reportlinker.com/p0490348/Hip-Resurfacing-Implants---Global-Pipeline-AnalysisCompetitive-Landscape-and-Market-Forecasts-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic Hip ...
Cached Medicine Technology:iPS Academia Japan, Inc. to Distribute Cellular Dynamics' iCell® Products in Japan 2iPS Academia Japan, Inc. to Distribute Cellular Dynamics' iCell® Products in Japan 3Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13
(Date:9/2/2015)... ... September 02, 2015 , ... Density ... or final products. Automating sample handling makes density measurements more efficient and error-free. ... step of the automated workflow and the advantages compared to manual sample handling. ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... Sciences clinical and academic partnership has earned international recognition as a premier center ... disorder that can cause sudden, catastrophic internal bleeding and stroke. , Cure ...
(Date:9/2/2015)... KY (PRWEB) , ... September 02, 2015 , ... Ericson ... the CDI Education Director for HCPro and Associate Director of Education for the Association ... CDI, Advancing CDI and ICD-10 for CDI Boot Camps. She serves as a CDI ...
(Date:9/2/2015)... Chicago, IL (PRWEB) , ... September 02, 2015 ... ... (COIES) is officially announced today. The two day international investment and business conference ... House Oct 9-11, 2015 in Beijing China. The full-weekend networking conference will feature ...
(Date:9/2/2015)... ... September 02, 2015 , ... SonicSurg Innovations, an ... announced today that more than 600 successful patient procedures have been performed utilizing ... nearly 70 of these procedures have been on triggering thumbs. , SonicSurg ...
Breaking Medicine News(10 mins):Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2
... Valley Credits Outsourcing Support as Contributor to Profit Gain ... CSC (NYSE: CSC ) today announced ... business process outsourcing (BPO) services for Aspen Valley Hospital ... disclosed.Under the new agreement, CSC will continue to provide ...
... AMERIGROUP Corporation (NYSE: AGP ) announced today ... Nevada began offering healthcare services to individuals enrolled in ... beginning February 1, 2009. "We,re pleased to begin serving ... Carlson, AMERIGROUP Chairman and Chief Executive Officer. "We ...
... in your fridge, chances are you,ll try it, experts say , , ... that expired yogurt at the back of the fridge? What about ... , If you,re like most Americans, you,ll take the chance, a ... people would quickly reject at the supermarket are much more eagerly ...
... Feb. 2 Despite increasingly dire economic news ... where demand for candidates far exceeds supply. Rehabilitation ... professionals among healthcare staffing agencies and medical facilities. ... employment slowdown, that is not the case for ...
... Feb. 2 EDI Health Group, Inc. (EHG), ... for patients, payers and providers in the dental ... (Nasdaq: QSII ) to serve as ... Division (QSI) and its providers and payers. , ...
... from celiac diseaseANN ARBOR, Mich., Feb. 2 Dorothy Carpenter ... a bite of bread or pasta could lead to terrible ... of Michigan Health System physician recognized it as celiac ... mass, a cancer that forced doctors to remove part of ...
Cached Medicine News:Health News:CSC Signs Five-Year Outsourcing Extension With Aspen Valley Hospital 2Health News:AMERIGROUP Health Plan in Nevada Begins Serving Medicaid Enrollees 2Health News:You Own It, You'll Eat It 2Health News:You Own It, You'll Eat It 3Health News:Need for Traveling Therapists Boosts Demand for Lead Services of AlliedTravelCareers.com 2Health News:EDI Health Group Selected by Quality Systems to Facilitate EDI Transactions Between Payers and Large Dental Group Practices 2Health News:EDI Health Group Selected by Quality Systems to Facilitate EDI Transactions Between Payers and Large Dental Group Practices 3Health News:GI Condition Once Thought Rare is Common in U.S. 2Health News:GI Condition Once Thought Rare is Common in U.S. 3
The Mid Field 30° lens has a bi-concave design to provide a wider field of view with a 30 degree offset image....
... The Chalam 30° Prism are ... and are recommended for tractional ... and Rhegmatogenus retinal detachment. They ... photocoagulation and other midperipheral laser ...
... Prism are designed for midperipherical ... for tractional retinal detachments (PDR, ... detachment. They can be used ... midperipheral laser applications. Direct image ...
... With somewhat higher magnification and increased ... suited for detailed visualization to the equatorial ... vitrectomy in diabetics and in membrane peeling ... (ACS) AutoClave Sterilizable Lenses The ACS Vitrectomy ...
Medicine Products: